Showing results (231-240 of 297) with videos related to

Sort By:
Pageof 30
Lakartidningen|December 18, 1998
[Study and treatment of heart failure require new approaches. Natriuretic peptides can be safe and simple diagnostic and outcome measures]G Lindstedt, C H Bergh, K Caidahl, et al.
British Heart Journal|April 1, 1984
Effect of metoprolol on chest pain in acute myocardial infarctionJ Herlitz, A Hjalmarson, S Holmberg, et al.
European Heart Journal|November 10, 2000
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trialL Rydén, P W Armstrong, J G Cleland, et al.
European Journal of Heart Failure|August 10, 2000
Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigatorsJ G Cleland, M Tendera, J Adamus, et al.
The American Journal of Cardiology|June 25, 1984
Göteborg Metoprolol Trial: design, patient characteristics and conductJ Herlitz, S Holmberg, K Pennert, et al.
Clinical Science (London, England : 1979)|December 10, 1999
Structural and functional assessment of small arteries in patients with chronic heart failureC Hillier, P J Cowburn, J J Morton, et al.
European Heart Journal|September 1, 1995
Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failureD P Dutka, I Olivotto, S Ward, et al.
Archives of Internal Medicine|February 15, 2001
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and SurvivalB M Massie, P W Armstrong, J G Cleland, et al.
European Heart Journal|August 23, 2000
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?N G Bellenger, M I Burgess, S G Ray, et al.
British Heart Journal|October 1, 1990
Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillationE L Ang, W L Chan, J G Cleland, et al.
Pageof 30